Roswell Park’s NCI designation renewed

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

NCI has renewed Roswell Park Comprehensive Cancer Center’s status as one of 50 Comprehensive Cancer Centers and awarded a $22.5 million Cancer Center Support Grant to fund core research and education programs.

This is the largest award of this type and highest application score in Roswell Park’s history.

“This is the most coveted and competitive distinction in cancer, and our team has once again demonstrated that we can serve our community in a way no one else can,” said Candace S. Johnson, Roswell Park president and CEO, in a statement.

“Roswell Park has strong basic science in many areas, an outstanding center director, and exceptional facilities,” the peer reviewers wrote in assessing Roswell Park’s application. “Roswell Park is an important regional and national resource for cancer research and care. Under the strong leadership of Johnson, and with the continued commitment of the Institution, Roswell Park is poised to continue its solid upward trajectory.”

YOU MAY BE INTERESTED IN

The nagging pain in Mia Sandino’s right knee set in in September 2018, and throughout her freshman year at the University of Washington, she tried to ignore it. “I was being a very naive and invincible-feeling 19-year-old,” Sandino told The Cancer Letter. “I didn’t put two and two together that this area of the knee that...

Rick Pazdur, MD, the newly appointed director for the Center for Drug Evaluation and Research at the FDA, has been described as “greyhound thin” as a result of his dedication to cycling and lifting weights in the gym each day and, for a long time, a vegetarian diet. I first met him when he was the director of the Office of Oncology Drug Products (ODP) within CDER, in 2009.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login